HEPATITIS A VACCINE
A complete, commercial scale highly reproducible process for producing stable hepatitis A virus (HAV) comprises optimized growth, harvest, and antigen purification conditions, to yield a >95% pure HAV on the basis of protein. Further processing steps yield an inactivated HAV vaccine formulation w...
Saved in:
Main Authors | , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
28.11.1995
|
Edition | 5 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A complete, commercial scale highly reproducible process for producing stable hepatitis A virus (HAV) comprises optimized growth, harvest, and antigen purification conditions, to yield a >95% pure HAV on the basis of protein. Further processing steps yield an inactivated HAV vaccine formulation which is immunogenic, well tolerated, and efficacious in protection against infection by virulent HAV. The product content of protein, carbohydrate, lipid, DNA and RNA is characterized. |
---|---|
AbstractList | A complete, commercial scale highly reproducible process for producing stable hepatitis A virus (HAV) comprises optimized growth, harvest, and antigen purification conditions, to yield a >95% pure HAV on the basis of protein. Further processing steps yield an inactivated HAV vaccine formulation which is immunogenic, well tolerated, and efficacious in protection against infection by virulent HAV. The product content of protein, carbohydrate, lipid, DNA and RNA is characterized. |
Author | BUCKLAND,BARRY C HENNESSEY,JOHN P AUNINS,JOHN G OLIVER,CYNTHIA NEWELL ORELLA,CHARLES J JUNKER,BETH SITRIN,ROBERT D DEPHILLIPS,PETER A ABOUD,ROBERT A HAGEN,ANNA J LEWIS,JOHN A |
Author_xml | – fullname: AUNINS,JOHN G – fullname: HAGEN,ANNA J – fullname: ORELLA,CHARLES J – fullname: HENNESSEY,JOHN P – fullname: SITRIN,ROBERT D – fullname: DEPHILLIPS,PETER A – fullname: ABOUD,ROBERT A – fullname: BUCKLAND,BARRY C – fullname: LEWIS,JOHN A – fullname: JUNKER,BETH – fullname: OLIVER,CYNTHIA NEWELL |
BookMark | eNrjYmDJy89L5WQQ9nANcAzxDPEMVnBUCHN0dvb0c-VhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfEeoSHmBpYWRo7GBBUAAGMnHws |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 5 |
ExternalDocumentID | HUT70982A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_HUT70982A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:16:01 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_HUT70982A3 |
Notes | Application Number: HU19950000417 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19951128&DB=EPODOC&CC=HU&NR=T70982A |
ParticipantIDs | epo_espacenet_HUT70982A |
PublicationCentury | 1900 |
PublicationDate | 19951128 |
PublicationDateYYYYMMDD | 1995-11-28 |
PublicationDate_xml | – month: 11 year: 1995 text: 19951128 day: 28 |
PublicationDecade | 1990 |
PublicationYear | 1995 |
RelatedCompanies | MERCK AND CO. INC |
RelatedCompanies_xml | – name: MERCK AND CO. INC |
Score | 2.4554448 |
Snippet | A complete, commercial scale highly reproducible process for producing stable hepatitis A virus (HAV) comprises optimized growth, harvest, and antigen... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
Title | HEPATITIS A VACCINE |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19951128&DB=EPODOC&locale=&CC=HU&NR=T70982A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PT4MwFH6Z06g3xd8_Fg6GW-MoBdoDMaxAwERGlC27LaMU42UuDuO_b0GmXnZr2uSl7_D1e6993yvAHXUxkba0EJOEIaI4DbEC28gRFi2pRUr3p8o3deIJeZzZsx68brQwbZ_Qr7Y5okKUUHiv2_N69XeJFbS1lev74k1NvT9EuRcYZScXa8IHagQjL8zGwZgbnHvxxEifvdwdMor9HdhVMbTbQCGcjhpJyuo_n0RHsJcpU8v6GHpyqcEB33y7psH-U_farYYd8NYnoMVh5udJnrzovj71OU_S8BQGUZjzGCnr818_5vGk24V1Bn2V3MsL0G2zZENBaGk6FVlgwapFpZKgQoWRAtuiuoTzLUautq5cw2ErvDZNhOkN9OuPT3mrqLMuBq3b3x-EcO4 |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT4MwFH-Z0zhvit8fk4Ph1jhKgXIghhUI6MaIwrLbMr6Ml7k4jP--pTL1slvTJr-0TX5977Xv9wpwR01MSr3UkFUSCxFu05CVYR0ZuUYLqpHC_MnyjYwgJY8zfdaB140WRtQJ_RLFETmjcs73WpzXq79LLFfkVq7vszfe9f7gJ7arFK1crHEfqOIObS-euBOmMGYHqRI924k5sCh2dmCX-9dmQwVvOmwkKav_9sQ_hL2YQy3rI-iUSwl6bPPtmgT74_a1mzdb4q2PQQq82EnCJHyRHXnqMBZG3gn0fS9hAeLo8991zIO0nYV2Cl0e3JfnIOtqYQ1yQgvVqMgC51a1qHgQlHE3Msd6Xl3A2RaQy60jt9ALkvFoPgqjpys4ECJsVUWYXkO3_vgsb7gZrbO-2IJvlERz4Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HEPATITIS+A+VACCINE&rft.inventor=AUNINS%2CJOHN+G&rft.inventor=HAGEN%2CANNA+J&rft.inventor=ORELLA%2CCHARLES+J&rft.inventor=HENNESSEY%2CJOHN+P&rft.inventor=SITRIN%2CROBERT+D&rft.inventor=DEPHILLIPS%2CPETER+A&rft.inventor=ABOUD%2CROBERT+A&rft.inventor=BUCKLAND%2CBARRY+C&rft.inventor=LEWIS%2CJOHN+A&rft.inventor=JUNKER%2CBETH&rft.inventor=OLIVER%2CCYNTHIA+NEWELL&rft.date=1995-11-28&rft.externalDBID=A&rft.externalDocID=HUT70982A |